Cara Therapeutics Inc (CARA)

19.88
0.38 1.95
NASDAQ : Health Care
Prev Close 19.50
Open 19.45
Day Low/High 19.12 / 20.85
52 Wk Low/High 4.26 / 23.61
Volume 2.59M
Avg Volume 1.91M
Exchange NASDAQ
Shares Outstanding 32.51M
Market Cap 575.06M
EPS -2.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Bull's Death Is Greatly Exaggerated: Cramer's 'Mad Money' Recap (Tuesday 6/20/17)

Bull's Death Is Greatly Exaggerated: Cramer's 'Mad Money' Recap (Tuesday 6/20/17)

The real exaggeration, says Jim Cramer, may be the influence of the bond market. But you can't ignore bonds, either.

Apple Is a Very Strong Brand, and Jim Cramer Is Sticking With the Stock: Mad Money

Apple Is a Very Strong Brand, and Jim Cramer Is Sticking With the Stock: Mad Money

Go inside Jim Cramer's Apple call.

Charles Schwab, Essent Group, Cara Therapeutics, MGM Growth Properties: 'Mad Money' Lightning Round

Charles Schwab, Essent Group, Cara Therapeutics, MGM Growth Properties: 'Mad Money' Lightning Round

Jim Cramer is bullish on Charles Schwab, Essent Group, Cara Therapeutics, and MGM Growth Properties.

Launch of Cannabis ETF May Not Be Best Option for Investors

Launch of Cannabis ETF May Not Be Best Option for Investors

Although a cannabis ETF launched in April, investors are still likely to find more value in buying individual stocks in the sector, according to traders.

Foot Locker, Cara Therapeutics, National Grid, TripAdvisor: 'Mad Money' Lightning Round

Foot Locker, Cara Therapeutics, National Grid, TripAdvisor: 'Mad Money' Lightning Round

Jim Cramer is bullish on Foot Locker, Cara Therapeutics, National Grid, and Home Depot.

Step Away From the Ledge: Cramer's 'Mad Money' Recap (Wednesday 5/24/17)

Step Away From the Ledge: Cramer's 'Mad Money' Recap (Wednesday 5/24/17)

Jim Cramer says that when it comes to alarming negativity and ridiculous exuberance, both extremes are wrong; investors need to get real.

Six Flags, Cara Therapeutics, Hertz Global Holdings: 'Mad Money' Lightning Round

Six Flags, Cara Therapeutics, Hertz Global Holdings: 'Mad Money' Lightning Round

Jim Cramer is bullish on Six Flags and Cara Therapeutics, but he's bearish on General Motors and Pandora.

Ignore That Man in the White House? Cramer's 'Mad Money' Recap (Wednesday 5/10/17)

Ignore That Man in the White House? Cramer's 'Mad Money' Recap (Wednesday 5/10/17)

Jim Cramer says he's amazed that stocks -- and gold, even -- are just yawning at Trump's move to fire FBI Director Comey.

Berkshire Hathaway, Southwest, Alaska Air: 'Mad Money' Lightning Round

Berkshire Hathaway, Southwest, Alaska Air: 'Mad Money' Lightning Round

Jim Cramer says he respects Buffett's judgment. Cramer's also bullish on some airline stocks.

Vive la U.S. Earnings: Cramer's 'Mad Money' Recap (Monday 4/24/17)

Vive la U.S. Earnings: Cramer's 'Mad Money' Recap (Monday 4/24/17)

Jim Cramer says a rally on French election results is fine, but don't forget great U.S. corporate earnings and merger activity.

Cara Therapeutics Announces Positive Data From Quantitative Phase 1 Trial Measuring Respiratory Safety Of I.V. CR845

- I.V. CR845 statistically equivalent to placebo across all measures of respiratory safety -

Jim Cramer -- Incyte Stock Is Red-Hot, Worth More Than $200 in a Takeout

Jim Cramer -- Incyte Stock Is Red-Hot, Worth More Than $200 in a Takeout

Incyte has been doing great, locking in deals with Bristol-Myers and Merck. It's worth a lot more in a takeover situation, Cramer said.

Fed Crashes the Party: Cramer's 'Mad Money' Recap (Wednesday 4/5/17)

Fed Crashes the Party: Cramer's 'Mad Money' Recap (Wednesday 4/5/17)

Jim Cramer stresses discipline here because, he says, a frothy market can quickly turn on investors.

5 Stocks Insiders Are Loading Up On

5 Stocks Insiders Are Loading Up On

Insiders at Tesla, Ford and three other companies have been scooping up shares of their own stock lately.

Health Care Vote Impacts Trump's Deal Maker Image

Health Care Vote Impacts Trump's Deal Maker Image

At stake is whether the Republicans can work out their differences.

First Week Of November 17th Options Trading For Cara Therapeutics (CARA)

Investors in Cara Therapeutics Inc saw new options become available this week, for the November 17th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 241 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Cara Therapeutics Reports Fourth Quarter And Full Year 2016 Financial Results

- Conference call today at 4:30 p.m. ET -

4 Small-Cap Biotech Stars

4 Small-Cap Biotech Stars

I'm still enthusiastic about the sector, but it is critical to also be prudent.